Product Images Etonogestrel/ethinyl Estradiol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 18 images provide visual information about the product associated with Etonogestrel/ethinyl Estradiol NDC 66993-605 by Prasco Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - etonogestrel 01

Figure 1 - etonogestrel 01

This appears to be a table showing the number of women with a blood clot out of 10,000 woman-years, divided by different categories including non-CHC users who are not pregnant, postpartum (up to 12 weeks only), and different age ranges.*

etonogestrel 01a

etonogestrel 01a

Chemical Structure - etonogestrel 02

Chemical Structure - etonogestrel 02

Etonogestrel is a type of hormonal birth control that is inserted under the skin. It is a progestin-only contraceptive that works by thickening the cervical mucus and thinning the lining of the uterus to prevent ovulation and fertilization. It offers long-term contraception for up to three years, and is 99% effective at preventing pregnancy when used correctly.*

Chemical Structure - etonogestrel 03

Chemical Structure - etonogestrel 03

Ethynyl estradiol is a synthetic form of the female hormone estrogen. It is used as a component of most hormonal contraceptive methods. Ethynyl estradiol helps to prevent pregnancy by inhibiting ovulation, thickening cervical mucus to prevent sperm from reaching the egg, and thinning the lining of the uterus to prevent implantation of a fertilized egg. It may also be used to treat certain menstrual disorders and acne.*

Figure 2 - etonogestrel 04

Figure 2 - etonogestrel 04

This text appears to be a label or record related to a medication called Etonogestrel. It includes the name of the medication, a code (EE), and a reference to its use with a vaginal ring. Additionally, it mentions numbers related to days after insertion. It is not possible to determine the full context or purpose of this record without additional information.*

Figure - etonogestrel 05

Figure - etonogestrel 05

This text describes various methods of birth control and their effectiveness. It provides statistics on pregnancy rates and lists the different types of contraceptives such as pills, patches, implants, IUDs, condoms, diaphragms, and fertility awareness methods such as tracking fertile days, spermicide, and withdrawal. It serves as a comprehensive guide to family planning.*

Figure - etonogestrel 06

Figure - etonogestrel 06

Figure A - etonogestrel 07

Figure A - etonogestrel 07

Figure B - etonogestrel 08

Figure B - etonogestrel 08

Figure C - etonogestrel 09

Figure C - etonogestrel 09

Figure D - etonogestrel 10

Figure D - etonogestrel 10

Figure E - etonogestrel 11

Figure E - etonogestrel 11

Figure F - etonogestrel 12

Figure F - etonogestrel 12

The text describes a medication in the form of a vaginal ring that contains a combination of etonogestrel and ethinyl estradiol.*

Figure G - etonogestrel 13

Figure G - etonogestrel 13

Figure H - etonogestrel 14

Figure H - etonogestrel 14

Figure I - etonogestrel 15

Figure I - etonogestrel 15

Figure J - etonogestrel 16

Figure J - etonogestrel 16

PRINCIPAL DISPLAY PANEL - 3 Ring Pouch Box - etonogestrel 17

PRINCIPAL DISPLAY PANEL - 3 Ring Pouch Box - etonogestrel 17

This is a description for a vaginal ring contraceptive medication package. The package has a tamper-evident seal and an area reserved for 2D serialization barcode, serial number, expiry, and lot. The medication should be stored refrigerated between 2-8°C and kept out of the reach of children. The medication is intended to prevent pregnancy, but does not protect against HIV infection (AIDS) and other sexually transmitted diseases. Each ring contains 117 mg etonogestrel and 2.7 mg ethinyl estradiol as active ingredients and ethylene vinylacetat copomer and magnesium stearate as an excipient. The product should not be exposed to direct sunlight or temperature above 30°C (96°F). The medication should be dispensed to a patient within four months from the date of dispensing or the expiration date, whichever comes first. The packaging includes a sachet pouch with an expiration date and a label for placement on the medication. The product is manufactured by Praseo Laboratories in the USA and Organon & Co. I in The Netherlands. For any product information, the user can call 865-525-0686.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.